Carlo M. Croce
Affiliations: | Biochemistry | Ohio State University, Columbus, Columbus, OH |
Area:
BiochemistryWebsite:
https://medicine.osu.edu/cancer-biology-genetics/directory/faculty/croce-carlo/pages/index.aspxGoogle:
"Carlo M. Croce"Bio:
https://www.tandfonline.com/doi/pdf/10.4161/cc.1.6.256
DOI: 10.4161/cc.1.6.256
Mean distance: (not calculated yet)
Parents
Sign in to add mentorHilary Koprowski | research scientist | 1970-1974 | Wistar Institute of Anatomy and Biology (ID Tree) |
Children
Sign in to add traineeGianpiero Di Leva | grad student | 2009 | |
Taewan Kim | grad student | 2007-2011 | Ohio State |
Sung-Suk Suh | grad student | 2012 | Ohio State |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Rampioni Vinciguerra GL, Capece M, Reggiani Bonetti L, et al. (2024) Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma. Signal Transduction and Targeted Therapy. 9: 31 |
Cataldo A, Cheung DG, Hagan JP, et al. (2023) Genetic Loss of miR-205 Causes Increased Mammary Gland Development. Non-Coding Rna. 10 |
Ng A, Lovat F, Shih AJ, et al. (2023) Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state. Proceedings of the National Academy of Sciences of the United States of America. 120: e2308658120 |
Kim T, Croce CM. (2023) MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies. Experimental & Molecular Medicine |
Fong LY, Huebner K, Jing R, et al. (2023) Zinc treatment reverses and anti-Zn-regulated miRs suppress esophageal carcinomas in vivo. Proceedings of the National Academy of Sciences of the United States of America. 120: e2220334120 |
Garofalo M, Di Leva G, Romano G, et al. (2022) Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation. Cancer Cell |
Pichiorri F, Suh SS, Rocci A, et al. (2022) Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. Cancer Cell |
Pichiorri F, Suh SS, Rocci A, et al. (2022) Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. Cancer Cell |
Garofalo M, Romano G, Di Leva G, et al. (2022) Retraction Note: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nature Medicine |
Garofalo M, Jeon YJ, Nuovo GJ, et al. (2022) Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. Plos One. 17: e0267628 |